Publication | Closed Access

Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer

Distinct MechanismsCancer ImmunosurveillancePancreatic CancerMedicineImmunologyTumor ImmunityPathologyImmune RegulationInnate ImmunityCancer BiologyCell BiologyKras-tp53 Co-alterationTumor Biology